ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617768 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617768; 2) Community: the network communities that were significantly associated with the response to NSC 617768; 3) Molecule: the relationships between components within communities and NSC 617768; 4) MDR: the compounds that were significantly associated with the NSC 617768.

NSC Compound Enrichment Correlation
NSC 70931 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- 0.0478540623811426 0.40991009
NSC 710587 Null 0.0478540623811426 0.50091605
NSC 715775 11H-Indolo[1,2-b]indazolium, 11-[[4-(dimethylamino)phenyl]methylene]-6-methyl-, trifluoromethanesulfonate 0.0478540623811426 0.56346928
NSC 718579 Null 0.0478540623811426 0.13093729
NSC 744075 Null 0.0478540623811426 0.66420908
NSC 748909 Chonemorphine 0.0478540623811426 0.30656794
NSC 753193 N-(2-(4-acetylpiperazin-1-yl)ethyl)-3-(3-chloro-5-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide 0.0478540623811426 0.26152568
NSC 758356 2-(1-(4-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide 1.18700570938368e-006 0.44782866
NSC 704330 Null 4.88335076207318e-005 0.15813105
Total:67  Current:67    [First] [Prev] [Next] [Last]